CCM
GBT

Crabel Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Crabel Capital Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-112,680
Closed -$7.67M – 114
2022
Q3 		$7.67M Buy
+112,680
New +$6.21M 4.48% 4

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Crabel Capital Management's GBT Position: Q4 2022 in Review

Crabel Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 112,680 shares — an estimated $7.67M sold.

Crabel Capital Management first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $7.67M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Crabel Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Crabel Capital Management sold 112,680 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $7.67M.
  • Crabel Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Crabel Capital Management's Global Blood Therapeutics, Inc. position peaked at $7.67M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Crabel Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.